Riktkurs.nu
EN | SV
HaldexMid CapHoist
Stockholm Stock Exchange | Mid Cap
Hansa Biopharma
-4.35%
Latest
-4.35%
3 months
DNB CarnegieCarnegieSEBSEB EquitiesRBC

Price Targets For Hansa Biopharma

AnalystPrice TargetDateUpside
DNB Carnegie33 SEKDec -25
-4.35%
Carnegie32 SEKFeb -25
SEB130 SEKJul -24
SEB Equities50 SEKJul -24
RBC172 SEKJun -22

About The Company

Hansa Biopharma AB is a Swedish biopharmaceutical company developing immunomodulatory enzyme treatments for rare immunological conditions. The company focuses on developing treatments for organ transplantation and autoimmune diseases.
Wikipedia

The information on Riktkurs.nu is for general information purposes only. Riktkurs.nu makes no guarantees of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to Riktkurs.nu or the information, products, services, or related information on Riktkurs.nu for any purpose. The recipient is recommended to complete his or her decision basis with the material deemed necessary. We reserve us for all types of errors as well as any malfunctions of the website. The information on Riktkurs.nu should not be seen as a recommendation to buy or sell a security.
© Riktkurs.nu 2026
Updated 1/9/2026 10:03:00 AM